Atox Bio announced new data in an animal model of necrotizing soft tissue infection (NSTI), commonly known as “flesh eating bacteria” demonstrating that administration of a single dose of AB103, given several hours after infection even without any antibiotics, increased survival in animals, and reduced tissue necrosis, inflammation and bacterial...
Read more
Blog
Leviticus Cardio Success With Ventricular Device
Leviticus Cardio, a portfolio company of the Mofet Venture Accelerator, owned by the Trendlines Group, recently performed a successful animal surgical trial using its wireless coplanar energy transfer system (CET) for ventricular assist devices (VAD). The surgery was performed at Assaf Harofeh Hospital and produced a 75% full system efficiency...
Read more
Avraham Raises $5.7 M
Avraham Pharmaceuticals Ltd. announced that Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, Pontifax, Clal Biotechnology Industries (TASE:CBI) and the Technion Research and Development Foundation Ltd. (TRDF) have invested an additional $ 5.7 million in the company. Following the current investment round, Yissum...
Read more
IP Seminar May 29 Tel Aviv
IP experts on the life sciences industry in China and Japan are among the attendees at Intellectual Property 2013 on May 29 at the Sheraton Hotel in Tel Aviv. The eight hour seminar is designed for In House IP executives and professionals, general counsels, CFOs, CEOs and their advisers who...
Read more
Pharmacovigilance Comes to Israel
A branch of The International Society of Pharmacovigilance (ISoP) is being founded in Israel. “We hope to increase awareness about pharmacovigilance in the local industry and among all stakeholders,” says Dr. Irene Fermont, a founding member and a vice-president of ADDS (Advanced Drug & Device Services). The need for improved...
Read more